Edwards Lifesciences: FDA 510(k) Clearances, Shared Predicate Lineage, and Recall History (1979 to 2026)

Consolidated U.S. FDA 510(k) premarket clearance cohort in Cardiovascular (primary filing hub: CA) reconciled with CDRH and openFDA historical recall notices from 1979 to 2026.

Review 167 FDA 510(k) clearances, 35 recalled K-numbers, and 192 cumulative 1976 to 2026 CDRH recall notices for Edwards Lifesciences on Predicate Ledger.

Reconciled U.S. FDA 510(k) and Recall Summary for Edwards Lifesciences
Regulatory MetricVerified Value
Entity ClassificationConsolidated MedTech Parent (4 FDA applicant names)
Clinical Advisory SpecialtyCardiovascular (Panel CV)
Cleared FDA 510(k) Submissions (1976 to 2026)167 clearances (134 California, 80.2%)
Cleared 510(k)s Linked to a Recall Notice35 K-numbers (20.96% of cleared cohort)
Cumulative Historical Recall Notices (1976 to 2026)192 notices (20 Class I, 171 Class II, 1 Class III)
Currently Open vs Historical Recall StatusCumulative 1976 to 2026 FDA archive total (192 notices); verify live open vs terminated status per notice in dossier
Implantable and Life-Sustaining Clearances22 implantable (13.2%) and 14 life-sustaining
Median FDA 510(k) Review Duration109 days (90th percentile: 257 days)

Related Filings Across Meru Platforms

Verified cross-ledger federal filings for Edwards Lifesciences across sibling Meru public-data platforms.

Cumulative recall counts span 1976 to 2026 across U.S. FDA CDRH and openFDA public archives and combine closed historical notices with any currently open field actions. Browse all device cohorts, 20 clinical specialties, Shared 510(k) Predicate Lineage Stage, or reconciliation methodology.

Meru AI Healthcare Data Engineering: Need custom healthcare data pipelines, identifier crosswalks, or workflow automation? Talk to Meru AI → · AI for Healthcare Practice · Healthcare Price & Patent-Cliff Crosswalk Guide.